Analyses according to the diagnostic groups showed that annual costs were 10.57 ( 95 % CI 7.09-15 .75 ) times higher for the true-positive and 1.67 ( 95 % CI 1.20-2 .32 ) times higher for the false-positive group compared with the control group .